GEODE CAPITAL MANAGEMENT, LLC

Position in LXEO — Lexeo Therapeutics, Inc.

CIK 1214717 BOSTON, MA

Position in LXEO

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$8,136,748

-$552,331 QoQ

Shares Held

1,747,959

+15.5% QoQ

Ownership

2.13%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#18

of 141 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,427,018 across 520 Biotechnology names. LXEO ranks #203 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,017,848	$2,989,245,636
2	REGN	Regeneron Pharmaceuticals, Inc.	2,625,810	$1,637,297,566
3	ALNY	Alnylam Pharmaceuticals, Inc.	2,635,840	$793,466,914
4	RVMD	Revolution Medicines, Inc.	3,942,676	$738,384,360
5	MRNA	Moderna, Inc.	9,710,335	$680,014,759
6	INCY	Incyte Corp	4,750,735	$538,543,319
7	RPRX	Royalty Pharma plc	8,058,048	$451,814,751
8	INSM	INSMED Inc	4,220,155	$449,952,925

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,136,748	1,747,959	+15.5%	Shares	Defined	2026-08-12
2026-03-31	$8,689,079	1,513,777	+4.7%	Shares	Defined	2026-05-15
2025-12-31	$14,357,656	1,445,887	+100.3%	Shares	Defined	2026-02-09
2025-09-30	$4,793,289	721,881	+24.9%	Shares	Defined	2025-11-12
2025-06-30	$2,323,884	578,081	-1.4%	Shares	Defined	2025-08-08
2025-03-31	$2,035,209	586,516	+3.4%	Shares	Defined	2025-05-13
2024-12-31	$3,733,379	567,383	+2.6%	Shares	Defined	2025-02-12
2024-09-30	$5,001,352	553,247	+86.5%	Shares	Defined	2024-11-12
2024-06-30	$4,757,656	296,612	+50.0%	Shares	Defined	2024-08-09
2024-03-31	$3,101,488	197,799	+97.0%	Shares	Defined	2024-05-13
2023-12-31	$1,347,649	100,421	—	Shares	Defined	2024-02-13
No filing history on record for this holder in this stock.